A secreted bacterial protease tailors the Staphylococcus aureus virulence repertoire to modulate bone remodeling during osteomyelitis.

PubWeight™: 1.31‹?› | Rank: Top 10%

🔗 View Article (PMC 3721972)

Published in Cell Host Microbe on June 12, 2013

Authors

James E Cassat1, Neal D Hammer, J Preston Campbell, Meredith A Benson, Daniel S Perrien, Lara N Mrak, Mark S Smeltzer, Victor J Torres, Eric P Skaar

Author Affiliations

1: Department of Pediatrics, Division of Pediatric Infectious Diseases, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

Articles citing this

Inter- and intraspecies metabolite exchange promotes virulence of antibiotic-resistant Staphylococcus aureus. Cell Host Microbe (2014) 1.52

Staphylococcus aureus toxins. Curr Opin Microbiol (2013) 1.46

Mechanism of Gene Regulation by a Staphylococcus aureus Toxin. MBio (2016) 1.40

Phenol-soluble modulins--critical determinants of staphylococcal virulence. FEMS Microbiol Rev (2014) 1.21

Myeloid-derived suppressor cells contribute to Staphylococcus aureus orthopedic biofilm infection. J Immunol (2014) 1.01

Bacterial Hypoxic Responses Revealed as Critical Determinants of the Host-Pathogen Outcome by TnSeq Analysis of Staphylococcus aureus Invasive Infection. PLoS Pathog (2015) 0.95

Temporal and stochastic control of Staphylococcus aureus biofilm development. MBio (2014) 0.94

Comparative impact of diverse regulatory loci on Staphylococcus aureus biofilm formation. Microbiologyopen (2015) 0.89

Rot is a key regulator of Staphylococcus aureus biofilm formation. Mol Microbiol (2015) 0.87

Staphylococcus aureus Fibronectin-Binding Protein A Mediates Cell-Cell Adhesion through Low-Affinity Homophilic Bonds. MBio (2015) 0.87

Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid. Infect Immun (2015) 0.86

Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) α3 peptide. FASEB J (2013) 0.86

Impact of the functional status of saeRS on in vivo phenotypes of Staphylococcus aureus sarA mutants. Mol Microbiol (2014) 0.83

Signatures of cytoplasmic proteins in the exoproteome distinguish community- and hospital-associated methicillin-resistant Staphylococcus aureus USA300 lineages. Virulence (2017) 0.83

Quorum-sensing regulation in staphylococci-an overview. Front Microbiol (2015) 0.81

Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence Therapy. Toxins (Basel) (2016) 0.81

PSM-Mec-A Virulence Determinant that Connects Transcriptional Regulation, Virulence, and Antibiotic Resistance in Staphylococci. Front Microbiol (2016) 0.80

Impact of individual extracellular proteases on Staphylococcus aureus biofilm formation in diverse clinical isolates and their isogenic sarA mutants. Microbiologyopen (2014) 0.80

Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells. Pathog Dis (2015) 0.79

Infectious Dose Dictates the Host Response during Staphylococcus aureus Orthopedic-Implant Biofilm Infection. Infect Immun (2016) 0.78

Staphylococcus aureus osteomyelitis: bad to the bone. Cell Host Microbe (2013) 0.78

Using Quantitative Spectrometry to Understand the Influence of Genetics and Nutritional Perturbations On the Virulence Potential of Staphylococcus aureus. Mol Cell Proteomics (2017) 0.78

Functional characteristics of the Staphylococcus aureus δ-toxin allelic variant G10S. Sci Rep (2015) 0.77

XerC Contributes to Diverse Forms of Staphylococcus aureus Infection via agr-Dependent and agr-Independent Pathways. Infect Immun (2016) 0.77

Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis. Front Cell Infect Microbiol (2015) 0.77

Impact of sarA and Phenol-Soluble Modulins on the Pathogenesis of Osteomyelitis in Diverse Clinical Isolates of Staphylococcus aureus. Infect Immun (2016) 0.76

Bad to the Bone: On In Vitro and Ex Vivo Microbial Biofilm Ability to Directly Destroy Colonized Bone Surfaces without Participation of Host Immunity or Osteoclastogenesis. PLoS One (2017) 0.75

Humanized Mouse Models of Staphylococcus aureus Infection. Front Immunol (2017) 0.75

Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Antimicrob Agents Chemother (2016) 0.75

The SaeRS Two-Component System of  Staphylococcus aureus. Genes (Basel) (2016) 0.75

Phenol-Soluble Modulins Contribute to Early Sepsis Dissemination Not Late Local USA300-Osteomyelitis Severity in Rabbits. PLoS One (2016) 0.75

Host-inherent variability influences the transcriptional response of Staphylococcus aureus during in vivo infection. Nat Commun (2017) 0.75

Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections. Front Cell Infect Microbiol (2017) 0.75

Is Staphylococcus lugdunensis significant in clinical samples? J Clin Microbiol (2017) 0.75

SaeRS Is Responsive to Cellular Respiratory Status and Regulates Fermentative Biofilm Formation in Staphylococcus aureus. Infect Immun (2017) 0.75

Staphylococcal protein A promotes osteoclastogenesis through MAPK signaling during bone infection. J Cell Physiol (2017) 0.75

Articles cited by this

Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. Anal Chem (1995) 9.39

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med (2007) 7.75

Osteomyelitis. Lancet (2004) 6.14

Passage of heme-iron across the envelope of Staphylococcus aureus. Science (2003) 4.83

Metal chelation and inhibition of bacterial growth in tissue abscesses. Science (2008) 4.55

Osteomyelitis. N Engl J Med (1997) 3.89

Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.89

IDPicker 2.0: Improved protein assembly with high discrimination peptide identification filtering. J Proteome Res (2009) 3.72

Shotgun identification of protein modifications from protein complexes and lens tissue. Proc Natl Acad Sci U S A (2002) 3.70

Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis (2009) 2.31

Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One (2010) 2.27

Internalization of Staphylococcus aureus by cultured osteoblasts. Microb Pathog (1995) 2.03

SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis. J Infect Dis (2010) 1.76

Influence of the two-component system SaeRS on global gene expression in two different Staphylococcus aureus strains. J Bacteriol (2006) 1.76

The SaeR/S gene regulatory system is essential for innate immune evasion by Staphylococcus aureus. J Infect Dis (2009) 1.74

Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis (2006) 1.68

Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun (2006) 1.63

Role of Staphylococcus aureus global regulators sae and sigmaB in virulence gene expression during device-related infection. Infect Immun (2005) 1.61

Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One (2010) 1.60

Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling. J Proteome Res (2010) 1.43

Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics (2006) 1.41

Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol (2011) 1.36

Transcription and translation products of the cytolysin gene psm-mec on the mobile genetic element SCCmec regulate Staphylococcus aureus virulence. PLoS Pathog (2011) 1.34

Studies on extracellular proteolytic enzymes from Staphylococcus aureus. II. Isolation and characterization of an EDTA-sensitive protease. Biochim Biophys Acta (1973) 1.25

Mechanisms of Staphylococcus aureus invasion of cultured osteoblasts. Microb Pathog (1999) 1.23

saeRS and sarA act synergistically to repress protease production and promote biofilm formation in Staphylococcus aureus. PLoS One (2012) 1.15

Novel phenol-soluble modulin derivatives in community-associated methicillin-resistant Staphylococcus aureus identified through imaging mass spectrometry. J Biol Chem (2012) 1.08

sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol Microbiol (2012) 1.08

Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins. J Bacteriol (2012) 1.06

Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Am J Pathol (2004) 1.04

Staphylococcus aureus - induced tumor necrosis factor - related apoptosis - inducing ligand expression mediates apoptosis and caspase-8 activation in infected osteoblasts. BMC Microbiol (2003) 1.00

Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones. J Lipid Res (2012) 0.99

Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun (2008) 0.96

Activation of the SspA serine protease zymogen of Staphylococcus aureus proceeds through unique variations of a trypsinogen-like mechanism and is dependent on both autocatalytic and metalloprotease-specific processing. J Biol Chem (2007) 0.93

Staphylococcus aureus protein A binding to osteoblast tumour necrosis factor receptor 1 results in activation of nuclear factor kappa B and release of interleukin-6 in bone infection. Microbiology (2012) 0.92

Acute haematogenous osteomyelitis in children: is there any evidence for how long we should treat? Curr Opin Infect Dis (2008) 0.89

Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am (2012) 0.89

Clinical outcomes of osteomyelitis patients infected with methicillin-resistant Staphylococcus aureus USA-300 strains. Am J Orthop (Belle Mead NJ) (2012) 0.87

Causative agents of osteomyelitis induce death domain-containing TNF-related apoptosis-inducing ligand receptor expression on osteoblasts. Bone (2010) 0.85

USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J (2009) 0.82

Articles by these authors

Passage of heme-iron across the envelope of Staphylococcus aureus. Science (2003) 4.83

Metal chelation and inhibition of bacterial growth in tissue abscesses. Science (2008) 4.55

Global gene expression in Staphylococcus aureus biofilms. J Bacteriol (2004) 4.46

The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci U S A (2007) 4.07

Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun (2003) 3.77

Nutritional immunity: transition metals at the pathogen-host interface. Nat Rev Microbiol (2012) 3.55

Modulation of eDNA release and degradation affects Staphylococcus aureus biofilm maturation. PLoS One (2009) 2.84

Iron in infection and immunity. Cell Host Microbe (2013) 2.77

Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect Immun (2002) 2.71

Nutritional immunity beyond iron: a role for manganese and zinc. Curr Opin Chem Biol (2009) 2.69

Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus. Cell Host Microbe (2011) 2.66

Zinc sequestration by the neutrophil protein calprotectin enhances Salmonella growth in the inflamed gut. Cell Host Microbe (2012) 2.66

Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice. PLoS Biol (2012) 2.58

A Staphylococcus aureus regulatory system that responds to host heme and modulates virulence. Cell Host Microbe (2007) 2.55

Staphylococcus aureus IsdB is a hemoglobin receptor required for heme iron utilization. J Bacteriol (2006) 2.54

Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol (2009) 2.52

Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology (2006) 2.36

Photothermal nanotherapeutics and nanodiagnostics for selective killing of bacteria targeted with gold nanoparticles. Biophys J (2005) 2.08

Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe (2013) 1.99

Neutrophil microbicides induce a pathogen survival response in community-associated methicillin-resistant Staphylococcus aureus. J Immunol (2008) 1.97

Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J Bacteriol (2005) 1.85

CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature (2012) 1.85

Staphylococcus aureus AgrA binding to the RNAIII-agr regulatory region. J Bacteriol (2004) 1.85

Staphylococcus aureus redirects central metabolism to increase iron availability. PLoS Pathog (2006) 1.81

Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A (2004) 1.77

Overcoming the heme paradox: heme toxicity and tolerance in bacterial pathogens. Infect Immun (2010) 1.74

Intracellular metalloporphyrin metabolism in Staphylococcus aureus. Biometals (2007) 1.71

Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol (2010) 1.71

Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLoS One (2011) 1.71

Factors contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA mutants. PLoS One (2008) 1.69

Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe (2010) 1.66

Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc Natl Acad Sci U S A (2013) 1.64

Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol (2011) 1.64

Role of sarA in the pathogenesis of Staphylococcus aureus musculoskeletal infection. Infect Immun (2003) 1.60

Epistatic relationships between sarA and agr in Staphylococcus aureus biofilm formation. PLoS One (2010) 1.60

Staphylococcus aureus fur regulates the expression of virulence factors that contribute to the pathogenesis of pneumonia. Infect Immun (2010) 1.59

Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe (2012) 1.58

Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun (2010) 1.54

Silent information regulator (Sir)T1 inhibits NF-κB signaling to maintain normal skeletal remodeling. J Bone Miner Res (2013) 1.54

Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol (2011) 1.51

Recombination, repair and replication in the pathogenic Neisseriae: the 3 R's of molecular genetics of two human-specific bacterial pathogens. Mol Microbiol (2003) 1.48

The molecular basis of functional bacterial amyloid polymerization and nucleation. J Biol Chem (2008) 1.47

Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration. PLoS Pathog (2012) 1.47

Ruffling of metalloporphyrins bound to IsdG and IsdI, two heme-degrading enzymes in Staphylococcus aureus. J Biol Chem (2008) 1.46

Investigation of biofilm formation in clinical isolates of Staphylococcus aureus. Methods Mol Biol (2007) 1.45

Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1. Proc Natl Acad Sci U S A (2013) 1.45

Is aseptic loosening truly aseptic? Clin Orthop Relat Res (2005) 1.43

The IsdG-family of haem oxygenases degrades haem to a novel chromophore. Mol Microbiol (2010) 1.40

Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res (2007) 1.38

Staphylococcus aureus haem oxygenases are differentially regulated by iron and haem. Mol Microbiol (2008) 1.37

Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Antimicrob Agents Chemother (2009) 1.37

Staphylococcus aureus elaborates leukocidin AB to mediate escape from within human neutrophils. Infect Immun (2013) 1.37

Detecting bacterial colonization of implanted orthopaedic devices by ultrasonication. Clin Orthop Relat Res (2002) 1.36

Defining the strain-dependent impact of the Staphylococcal accessory regulator (sarA) on the alpha-toxin phenotype of Staphylococcus aureus. J Bacteriol (2011) 1.36

CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation. Mol Microbiol (2011) 1.34

Signaling and DNA-binding activities of the Staphylococcus aureus HssR-HssS two-component system required for heme sensing. J Biol Chem (2007) 1.34

Impact of sarA on antibiotic susceptibility of Staphylococcus aureus in a catheter-associated in vitro model of biofilm formation. Antimicrob Agents Chemother (2009) 1.32

Bone formation is impaired in a model of type 1 diabetes. Diabetes (2005) 1.32

Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis. Infect Immun (2007) 1.27

Cytoskeletal defects in Bmpr2-associated pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol (2011) 1.25

Development of a novel, highly quantitative in vivo model for the study of biofilm-impaired cutaneous wound healing. Wound Repair Regen (2011) 1.23

The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. J Orthop Res (2002) 1.21

Characterization of Staphylococcus aureus SarA binding sites. J Bacteriol (2003) 1.19

Subcellular localization of the Staphylococcus aureus heme iron transport components IsdA and IsdB. Infect Immun (2009) 1.18

Alpha-toxin induces programmed cell death of human T cells, B cells, and monocytes during USA300 infection. PLoS One (2012) 1.18

Two heme-dependent terminal oxidases power Staphylococcus aureus organ-specific colonization of the vertebrate host. MBio (2013) 1.17

MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun (2013) 1.17

Staphylococcus aureus SarA is a regulatory protein responsive to redox and pH that can support bacteriophage lambda integrase-mediated excision/recombination. Mol Microbiol (2009) 1.17

Impact of extracellular nuclease production on the biofilm phenotype of Staphylococcus aureus under in vitro and in vivo conditions. Infect Immun (2012) 1.16

Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A (2009) 1.15

saeRS and sarA act synergistically to repress protease production and promote biofilm formation in Staphylococcus aureus. PLoS One (2012) 1.15

Atf4 regulates chondrocyte proliferation and differentiation during endochondral ossification by activating Ihh transcription. Development (2009) 1.15

Protein-protein interactions among Helicobacter pylori cag proteins. J Bacteriol (2006) 1.14

Metal limitation and toxicity at the interface between host and pathogen. FEMS Microbiol Rev (2014) 1.14

Staphylococcus aureus HrtA is an ATPase required for protection against heme toxicity and prevention of a transcriptional heme stress response. J Bacteriol (2008) 1.13

Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity. Semin Immunopathol (2011) 1.13

Bacterial survival amidst an immune onslaught: the contribution of the Staphylococcus aureus leukotoxins. PLoS Pathog (2013) 1.12

A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect (2011) 1.12

Control of copper resistance and inorganic sulfur metabolism by paralogous regulators in Staphylococcus aureus. J Biol Chem (2011) 1.12

Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One (2012) 1.11

Structural basis for hemoglobin capture by Staphylococcus aureus cell-surface protein, IsdH. J Biol Chem (2011) 1.11

Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm. Clin Orthop Relat Res (2015) 1.11

Small molecule inhibitors of Staphylococcus aureus RnpA alter cellular mRNA turnover, exhibit antimicrobial activity, and attenuate pathogenesis. PLoS Pathog (2011) 1.10

Bacillus anthracis HssRS signalling to HrtAB regulates haem resistance during infection. Mol Microbiol (2009) 1.10

Functional amyloids signal their arrival. Sci Signal (2009) 1.09

Mutation of traP in Staphylococcus aureus has no impact on expression of agr or biofilm formation. Infect Immun (2007) 1.09

Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One (2011) 1.08

Acinetobacter baumannii increases tolerance to antibiotics in response to monovalent cations. Antimicrob Agents Chemother (2009) 1.08